Andean Precious Metals (CVE:APM) Shares Down 9.6% – What’s Next?

Shares of Andean Precious Metals Corp. (CVE:APM) fell 9.6% during mid-day trading on Tuesday . The stock traded as low as C$1.12 and last traded at C$1.13. 288,829 shares were traded during mid-day trading, an increase of 50% from the average session volume of 191,939 shares. The stock had previously closed at C$1.25.

Analyst Ratings Changes

Separately, Desjardins raised Andean Precious Metals to a “moderate buy” rating in a research note on Thursday, October 31st.

Andean Precious Metals Price Performance

The company has a market cap of C$167.28 million, a P/E ratio of 2.95 and a beta of 1.22. The company’s 50-day moving average price is C$1.46 and its 200-day moving average price is C$1.25.

Insider Transactions at Andean Precious Metals

In other news, insider 2176423 Ontario Ltd. bought 84,400 shares of the firm’s stock in a transaction dated Tuesday, October 8th. The shares were bought at an average price of C$1.51 per share, with a total value of C$127,359.60. Insiders bought 306,200 shares of company stock valued at $432,953 over the last three months. Company insiders own 69.37% of the company’s stock.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.